Composition
- Active ingredients
- ERYTHROMYCIN ESTOLATE EQ 250MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ERYTHROMYCIN ESTOLATE EQ 125MG BASE/5ML · For suspensionANDA061893-001 · Discontinued
- ERYTHROMYCIN ESTOLATE EQ 125MG BASE/5ML · SuspensionNDA050010-001 · Discontinued
- ERYTHROMYCIN ESTOLATE EQ 250MG BASE/5ML · SuspensionNDA050010-002 · Discontinued
- ERYTHROMYCIN ESTOLATE EQ 100MG BASE/ML · Suspension/dropsANDA061894-003 · Discontinued
- ERYTHROMYCIN ESTOLATE EQ 125MG BASE/5ML · SuspensionANDA061894-001 · Discontinued
- ERYTHROMYCIN ESTOLATE EQ 250MG BASE/5ML · SuspensionANDA061894-002 · Discontinued
- ERYTHROMYCIN ESTOLATE EQ 250MG BASE · Tablet, chewableANDA061895-002 · Discontinued
- ERYTHROMYCIN ESTOLATE EQ 125MG BASE · Tablet, chewableANDA061895-001 · Discontinued
- ERYTHROMYCIN ESTOLATE EQ 500MG BASE · TabletANDA061896-001 · Discontinued
- ERYTHROMYCIN ESTOLATE EQ 125MG BASE · CapsuleANDA061897-001 · Discontinued
- ERYTHROMYCIN ESTOLATE EQ 250MG BASE · CapsuleThis page
Official product information
At a glance
- Brand name
- Ilosone
- Active substance
- erythromycin estolate
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Lilly
- Status
- Discontinued
- FDA approval
- 6 Jan 1975
- Application
- ANDA061897-002